Finn Thorup Sellebjerg
Clinical Professor
- 2011
- Published
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production
Hedegaard, C. J., Sellebjerg, Finn Thorup, Krakauer, M., Hesse, D., Bendtzen, K. & Nielsen, Claus Henrik, 1 May 2011, In: Multiple Sclerosis. 17, 5, p. 567-77 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1
Nexø, B. A., Christensen, T., Frederiksen, J., Møller-Larsen, A., Oturai, A. B., Fredsted, P. V., Hansen, B., Nissen, K. K., Laska, M. J., Petersen, T. S., Bonnesen, S., Hedemand, A., Wu, T., Wang, X., Zhang, X., Brudek, T., Maric, R., Søndergaard, H. B., Sellebjerg, F., Brusgaard, K. & 7 others, , 1 Feb 2011, In: P L o S One. 6, 2, p. e16652 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?
Hesse, D., Krakauer, M., Lund, H., Søndergaard, H. B., Limborg, S. J. W., Sørensen, P. S., Sellebjerg, F., Hesse, D., Krakauer, M., Søndergaard, H. B., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, Feb 2011, In: European journal of neurology : the official journal of the European Federation of Neurological Societies. 18, 2, p. 266-72 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655
Søndergaard, H. B., Sellebjerg, Finn Thorup, Hillert, J., Olsson, T., Kockum, I., Lindén, M., Mero, I., Myhr, K., Celius, E. G., Harbo, H. F., Christensen, J. R., Börnsen, L., Sørensen, Per Soelberg & Oturai, A. B., 2011, In: European Journal of Human Genetics. 19, 10, p. 1100-3 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
Khademi, M., Kockum, I., Andersson, M. L., Iacobaeus, E., Brundin, L., Sellebjerg, Finn Thorup, Hillert, J., Piehl, F. & Olsson, T., 2011, In: Multiple Sclerosis. 17, 3, p. 335-43 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C. C. A., Patsopoulos, N. A., Moutsianas, L., Dilthey, A., Su, Z., Freeman, C., Hunt, S. E., Edkins, S., Gray, E., Booth, D. R., Potter, S. C., Goris, A., Band, G., Oturai, A. B., Strange, A., Saarela, J., Bellenguez, C. & 31 others, , 2011, In: Nature. 476, 7359, p. 214-9 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis
Sellebjerg, Finn Thorup, Hedegaard, C. J., Krakauer, M., Hesse, D., Lund, H., Nielsen, Claus Henrik, Søndergaard, H. B. & Sørensen, Per Soelberg, 2011, In: Multiple Sclerosis.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab
Sørensen, Per Soelberg, Jensen, P. E. H., Haghikia, A., Lundkvist, M., Vedeler, C., Sellebjerg, Finn Thorup, Koch-Henriksen, N., Fogdell-Hahn, A., Myhr, K., Hillert, J. & Gold, R., 2011, In: Multiple Sclerosis. 17, 9, p. 1074-8 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
Börnsen, L., Khademi, M., Olsson, T., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2011, In: Multiple Sclerosis. 17, 1, p. 32-42 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
Sørensen, Per Soelberg, Lycke, J., Erälinna, J., Edland, A., Wu, X., Frederiksen, J. L., Oturai, A., Malmeström, C., Stenager, E., Sellebjerg, Finn Thorup, Sondergaard, H. B. & SIMCOMBIN study investigators, S. S. I., 2011, In: Lancet Neurology. 10, 8, p. 691-701 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 923247
Most downloads
-
503
downloads
Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
220
downloads
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
191
downloads
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published